NHSO agrees to 4 'pricey' medicines

The National Health Security Office (NHSO) board recently approved the universal health scheme's coverage of four extra medicines, which were necessary but rather expensive, NHSO deputy chief Netnapis Suchonwanich said on Sunday.

They are: Trastuzumab, prescribed for early-stage breast cancer; Nilotinib, prescribed for chronic myeloid leukemia; Dasatinib, prescribed for chronic myeloid leukemia for patients with resistance to Imatinib and Nilotinib; and Peg-Interferon prescribed for the treatment of hepatitis.

NHSO agrees to 4 'pricey' medicines

The National Health Security Office (NHSO) board recently approved the universal health scheme's coverage of four extra medicines, which were necessary but rather expensive, NHSO deputy chief Netnapis Suchonwanich said on Sunday.

MOST VIEWED

China's President Xi makes state visit to Vietnam

Fruit yields up in 2025; Durian hits 1.6 million tons

Thai engineer denies involvement in SAO building collapse in Bangkok

Songkran revellers pack Sanam Luang for festive water fight

DMR explains Krabi minor quake caused by Khlong Marui Fault